A randomized controlled trial evaluating the efficacy and...

Clinical Immunology 2003 Vol. 106; Iss. 3

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human Interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100–300 CD4+ t cells

Alberdina W de Boer, Norman Markowitz, H.Clifford Lane, Louis D Saravolatz, Susan L Koletar, Haig Donabedian, Carl Yoshizawa, Anne-Marie Duliege, Gwendolyn Fyfe, Ronald T Mitsuyasu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
106
Year:
2003
Language:
english
DOI:
10.1016/s1521-6616(02)00038-4
File:
PDF, 109 KB
english, 2003
Conversion to is in progress
Conversion to is failed